Diversity in Clinical Trials: The Need to Take Action
Gadi Saarony, CEO of Advarra discusses the current state of diversity in clinical trials and how industry needs to be more proactive in addressing it.
Gadi Saarony, CEO of Advarra examines the current state of diversity in clinical research. He discusses the need for industry to take more action in making trials more diverse, what regulatory bodies need to do to increase awareness, and how researchers can best reach diverse populations.
About the speaker
Gadi Saarony, CEO of Advarra has over 25 years of leadership experience, including commercial and operational clinical research roles. Prior to joining Advarra, he served as Executive Vice President and Chief Clinical Research Services Officer at Parexel where he was responsible for operational delivery of company research services such as patient recruitment and data management.
About the ACT Podcast
The editors of Applied Clinical Trials bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Listen to this podcast on Spotify and Google Podcasts
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Addressing Racial Disparities in Lupus Clinical Trials
January 6th 2025Study finds that addressing racial disparities in lupus clinical trials requires targeted education, increased diversity among trial staff, culturally sensitive recruitment strategies, and addressing social determinants of health to improve Black patient participation.
